Clay Ransdell, DO
Pain Medicine · West Des Moines, IANPI 1942207659
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 34 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Nevro Corp. at 31.6% of the total. Reporting peaked in 2019 at $184 and has fallen 66.9% since, to $61 in 2025. That places this record below the midpoint for pain medicine clinicians in IA, where the typical reported total is $2,859.
Across 34 payments — averaging $18.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$203
- AbbVie$97
- Si-bone, Inc.$83
- Abbott$81
- Boston Scientific$31
- Vertos Medical, Inc.$30
- plus $118 from 6 others
What the payments were for
- Food & beverage$642100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 11 | $203 |
| AbbVie(2 entities) | 5 | $97 |
| Si-bone, Inc. | 3 | $83 |
| Abbott | 5 | $81 |
| Boston Scientific | 2 | $31 |
| Vertos Medical, Inc. | 2 | $30 |
| Vertex | 1 | $27 |
| Novartis | 1 | $23 |
| SPR Therapeutics, Inc | 1 | $20 |
| Biodelivery Sciences International, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
How this compares
$642 in reported general payments places this provider in the 25th percentile of 31 pain medicine providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 89 | $2,127 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 29 | $653 |
| Tramadol Hcl | 48 | $355 |
| Oxycodone Hcl | 13 | $284 |
| Cyclobenzaprine Hcl | 22 | $231 |
| Pregabalin | 24 | $217 |
| Gabapentin | 30 | $211 |
| Diclofenac Sodium | 13 | $141 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in West Des Moines
- Christopher StalveyWest Des Moines$14K
- Jun XuWest Des Moines$4K
- Arpan PatelWest Des Moines$3K
- Steven QuamWest Des Moines$1K
- James SykesWest Des Moines$861
- Andrew SpellmanWest Des Moines$304
- Kenneth PollackWest Des Moines$0
- Garry ClarkSioux City$189K
- Jolene SmithClive$85K
- Daniel MoyseDes Moines$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.